Term ends Jan 6, 2043 · High confidence
20-year base term ends Nov 2, 2041
Held by Black Diamond Therapeutics, Inc.
Filed May 1, 2023 as application 18/034,749 · Granted Aug 25, 2026
Base term plus 544 days of patent term adjustment (USPTO delay) · capped by a resolved terminal disclaimer
Today
2021
2043
Clock starts
Nov 2, 2021
Nov 2, 2021
Term ends
Jan 6, 2043
Jan 6, 2043
Granted
Aug 25, 2026
Aug 25, 2026
base term
patent term adjustment
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
544
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
Capped
Terminal disclaimer
Resolved from the filed document, referencing US 12,435,046.
0 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
3
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.
This patent's term runs 544 days past its 20-year base term on prosecution delay. A terminal disclaimer resolved from the filed document caps it earlier. 0 of 3 maintenance fees are paid so far. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Nov 2, 2021, when application PCT/US2021/057724, the earliest non-provisional in its chain, was filed (this one was filed May 1, 2023) | Nov 2, 2041 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +544 days, USPTO patent term adjustment record | Apr 30, 2043 | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 12,435,046) | capped to Jan 6, 2043 | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 0 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Jan 6, 2043 | High confidence |
This family
| Application PCT/US2021/057724 | PCT application no patent term | no patent term |
| US 12,714,713 | this patent Jan 2043 | Jan 2043 |
| Application 19/744,145 | Pending not computed | not computed |
Every application listed has its file history here. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Dec 19, 2023 Reel 65907, frame 257 | Buck, Elizabeth; O'connor, Matthew; Romashko, Darlene; Lin, Tai-an; Wrona, Iwona; Lucas, Matthew C; Roberts, Chris; Smith, Sherri; Waters, Nigel | Black Diamond Therapeutics, Inc. | Assignment of Assignor's Interest |
| Dec 19, 2023 Reel 65907, frame 286 | Flohr, Alexander; Arista, Luca; Ottaviani, Giorgio | Ridgeline Therapeutics GmbH | Assignment of Assignor's Interest |
| Dec 19, 2023 Reel 65907, frame 336 | Ridgeline Therapeutics GmbH | Black Diamond Therapeutics, Inc. | Assignment of Assignor's Interest |
| Apr 8, 2025 Reel 70772, frame 793 | Epstein, David M. | Black Diamond Therapeutics, Inc. | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Jan 2043
Term ends Jan 6, 2043. Maintenance fees still fall due before then
Note
The 544 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Disclaimer cap
This term is capped by a terminal disclaimer resolved from the filed document, referencing US 12,435,046.
Citations
We have no citation count for this patent yet. That is not the same as never having been cited.
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.